Member Info for Latino

Next RNS could well be on interest on the range of potential customer they’ve already provided the product to..before registration?

In parallel, the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product.

II’s very likely all over this stock now, patience is the key here. The product is already self certified hence submission is a paper exercise for registration so it’s rather about when than IF!

Following self-certification, the Genedrive(R) COV19-ID Kit has been passed to genedrive's Authorised Representative for formal registration, a process expected to take ten working days to complete, following which the product can be made available commercially in the European Union. In parallel, the product is being provided for review and evaluation to a range of potential commercial partners who have actively expressed interest in the product.

Hopefully Up we go…

35p might have gone…that’s what you get for being too greedy lol what’s 1/2 a pence on grand scheme of things!

Very likely IIs are all over this…gla

Some battle…SP looks to be fighting back

Don’t place stop losses if you’re not looking to sell, MMs will have you!

Smart money moving in here, hugh buyer taking advantage of profit taking…on the move now!

Premium paid at 0.397

Apologies wrong board!

Just…

Hilarious lol…guess you just have to wait 17min!

Very hard to trade and buys flooding in…gla

Auction again…

Live price now 31p buy..

David Budd, CEO of genedrive plc, said: "I am delighted to say that development work from the Company has resulted in designing and delivering a product with excellent performance specifications and a speed to result that is a new benchmark. The new Genedrive ®COV19-ID Kit combines the speed and ease of lateral flow testing with molecular level accuracy in a low cost and portable device. We are now able to progress the commercial evaluations of the product to selected partners and given its performance in our studies, we believe there remain substantial market opportunities that can be targeted. As recent news of the Omicron variant demonstrates, COVID-19 remains a significant issue in global health and thus rapid and accurate testing will remain a critical tool in managing the spread of the virus."

To buy…can’t buy now for last 20min

Now..break out

It looks like blue sky’s from here….after long period of depressed SP!

For those Chartists…